Product
SIIV
1 clinical trial
3 indications
Indication
COVID-19Indication
InfluenzaIndication
HumanClinical trial
A Phase I/IIa Study to Evaluate Safety and Immunogenicity of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy VolunteersStatus: Completed, Estimated PCD: 2021-09-30